Catalent Pharma Solutions has received The Procter & Gamble Company’s (P&G) highest external business partner recognition, the External Business Partner of the Year Award.
 
The award recognizes the performance of Catalent’s two state-of-the-art softgel manufacturing facilities in Ontario, Canada which have been supplying P&G Personal Healthcare brands in the U.S. and Canada. Catalent also launched additional cough and cold OTC product line extensions with P&G in 2018, which are supplied from Catalent’s facilities in Ontario.
 
“Catalent has been P&G’s preferred softgel supplier for twenty years,” said Aris Gennadios, president, Catalent Softgel Technologies. “We continue to collaborate closely with P&G Personal Healthcare to bring innovative products to consumers.”
 
“I congratulate and thank all of our award winners. They are critical partners in accomplishing our purpose,” said Stew Atkinson, chief purchasing officer, P&G. “P&G’s supplier eco-systems are creating value for consumers, customers, P&G and our suppliers. I am proud of what we have accomplished, and we will continue to raise the bar on superiority, productivity and citizenship together.”
 
Catalent’s Ontario facilities in Strathroy and Windsor offer softgel development and manufacturing capabilities for both the pharmaceutical and consumer health industries. The two sites combine integrated formulation, manufacturing, analytical and packaging services to provide full service turnkey solutions to partners.